About Empire Genomics
Empire Genomics is a company based in Buffalo (United States) founded in 2006 was acquired by Biocare Medical in November 2022. It operates as a Direct-to-Consumer (D2C) and Professional Services. Empire Genomics has raised $3.3 million across 7 funding rounds from investors including Biocare Medical, NIH and HHS. The company has 14 employees. Empire Genomics has completed 1 acquisition, including ID Labs. Empire Genomics offers products and services including FISH Probes, Custom FISH Probe Design, and FISH Ancillaries. Empire Genomics operates in a competitive market with competitors including Neogen, Parse Biosciences, Qiagen, Biofidelity and Novogene Corporation, among others.
- Headquarter Buffalo, United States
- Employees 14
- SectorsHealthcare
- Phone•••• ••••
- Website empiregenomics.com
- Social LinkedIn X Facebook
- Acquired by Biocare Medical (Nov 2022)
- Legal Name Empire Genomics, A Biocare Medical Company
- Total Equity Funding$3.3M (USD)
in 7 rounds
- Latest Funding Round$1.75M (USD), Series A
May 2016
- InvestorsBiocare Medical
& 6 more
- Employee Count14
- Investments & Acquisitions
- Acquired byBiocare Medical
(Nov 2022)
Products & Services of Empire Genomics
Empire Genomics offers a comprehensive portfolio of products and services, including FISH Probes, Custom FISH Probe Design, and FISH Ancillaries.
FISH probes are provided for clinical diagnostics.
Custom FISH probes are designed per client needs.
Ancillary reagents are offered for FISH testing accuracy.
Funding Insights of Empire Genomics
Empire Genomics has successfully raised a total of $3.3M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $1.75 million completed in May 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.3M
- Total Rounds 7
- Last Round Series A — $1.75M
- Investors Count 6
All 7 funding rounds of Empire Genomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2016 | $1.75M | Series A | – | Broadoak Capital Partners | |
| Feb 2016 | $300,000 | Series A | – | Rand Capital | – |
| Nov 2014 | $1.25M | Seed | – | Rand Capital, Z80 Labs | – |
| May 2013 | $142,432 | Grant | – | – | |
| Apr 2013 | $142,432 | Grant | – | – | |
| Aug 2010 | $400,000 | Grant | – | – | |
| Jun 2008 | – | Seed | – | – | – |
7 investors in total: 7 institutional.
Investors in Empire Genomics
Empire Genomics has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Biocare Medical, NIH and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early & Growth stage VC Firm investing primarily in the US | 1969 | randcapital.com | Buffalo, United States | |
- | – | z80labs.com | - | |
Empire State Development is focused on economic growth in New York. | – | esd.ny.gov | New York, United States | |
Investment banking services are offered in the United States. | 2006 | broadoak.com | Bethesda, United States | |
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
Primary antibodies and instruments for immunohistochemistry are manufactured. | 1997 | biocare.net | Concord, United States |
Investor details for Empire Genomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Empire Genomics
2 people are tracked at Empire Genomics (1 in leadership, 1 in team); the tracked headcount is 14.
| Name | Role | Group |
|---|---|---|
Norma Nowak | Chief Scientific Officer and Founder | Leadership |
Robyn Hammond | Manufacturing Lab Manager | Team |
Complete people profiles for Empire Genomics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Empire Genomics
Empire Genomics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include ID Labs.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Custom molecular biology and immunologic research services are provided. | idlabs.com | London, Canada | 1989 | Jan 2015 | •••• |
Complete acquisition details for Empire Genomics
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Empire Genomics
5 dated milestones of Empire Genomics across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Empire Genomics is founded.
- Funding First funding round.
- Acquisition Acquires ID Labs.
- Funding Latest funding round, Series A, of $1.8M.
- Exit Acquired by Biocare Medical.
Competitors of Empire Genomics
Empire Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neogen, Parse Biosciences, Qiagen, Biofidelity and Novogene Corporation, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| neogen.com | 1982 | Lansing, United States | $700,000 | 2,640 | Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing | |
| parsebiosciences.com | 2018 | Seattle, United States | $100.26M | – | RNA-sequencing transcriptome kits for health data analysis are developed. | |
| qiagen.com | 1984 | Hilden, Germany | – | 104 | Products and reagents for molecular diagnostic assays are supplied. | |
| biofidelity.com | 2002 | Cambridge, United Kingdom | $59.91M | 28 | Molecular diagnostic assays are developed for target DNA sequence detection. | |
| novogene.com | 2011 | Beijing, China | $75M | 141 | Genomic services and solutions with NGS expertise are provided. | |
| fluentbio.com | 2018 | Watertown, United States | $19M | – | Proprietary reagents for single-cell genetic analysis are developed. | |
| rarecyte.com | 2009 | Seattle, United States | $114.33M | 54 | Developer of technologies for the analysis of rare and single cells in the blood | |
| rejuvenatebio.com | 2017 | San Diego, United States | $14.58M | 39 | Gene-editing platform and anti-aging therapy for dogs are developed. | |
| sourcebioscience.com | 1903 | Nottingham, United Kingdom | – | 273 | Multiple genomic services are provided for analysis and diagnostics. |
Detailed competitors of Empire Genomics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Empire Genomics
The website of Empire Genomics (empiregenomics.com) receives about 2.1K visits a month.
- Monthly visits2.1K
▼ 16.2% vs previous month
Websites whose visitors overlap most with Empire Genomics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
genome.ym.edu.tw | genome.ym.edu.tw | 100% | – | – | – |
| bionanogenomics.com | 88% | – | #4,512,022 | View details | |
| rubicongenomics.com | 88% | – | – | View details | |
usgenomics.com | usgenomics.com | 88% | – | – | – |
jgenomics.com | jgenomics.com | 87% | – | #12,611,210 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for Empire Genomics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Empire Genomics
Complete news archive for Empire Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Empire Genomics
10 companies that operate in the same segment as Empire Genomics (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Empire Genomics
Empire Genomics was founded in 2006 and raised its 1st funding round 2 years after it was founded.
Empire Genomics is headquartered in Buffalo, United States. It is registered at Buffalo, New York, United States.
Empire Genomics is a funded company, having raised a total of $3.3M across 7 funding rounds to date.
Empire Genomics has 14 employees.
Empire Genomics is engaged in offering reliable FISH testing solutions for clinical diagnostics and research applications. A comprehensive catalog of probes and ancillary reagents is provided, leveraging an extensive BAC library from the Human Genome Project. Solutions are created for a wide range of applications, from discovery and development to routine testing in clinical labs. Rapid turnaround times are ensured, with next-day shipping for in-stock products and custom designs completed in as little as two weeks. The company is dedicated to serving as a trusted partner in the healthcare and biotechnology sectors, focusing on precision and quality in diagnostics.
Empire Genomics's top competitors include Neogen, Novogene Corporation and Qiagen.
Empire Genomics offers FISH Probes, Custom FISH Probe Design, and FISH Ancillaries.
Empire Genomics has made 1 acquisition, including ID Labs.
Empire Genomics has 7 investors. Key investors include Biocare Medical, NIH, HHS, Broadoak Capital Partners, and Rand Capital.
Empire Genomics operates through Empire Genomics, A Biocare Medical Company.
Yes. Empire Genomics was acquired by Biocare Medical in November 2022.